Northrop Grumman’s narrative has shifted subtly but decisively, as a largely unchanged fair value estimate near $667.21 per share now sits against a backdrop of a slightly higher discount rate of about 8.20 %, reflecting a modest uptick in perceived risk and required return. With revenue growth expectations holding near 5.43 % and Street research coalescing around mid to high $600s price targets supported by robust program backlogs, nuclear deterrence programs, and long term cash flow visibility, the stock’s valuation story is being reinforced rather than rewritten. Stay tuned to see how you can track these evolving assumptions and price targets so you remain ahead of the next narrative shift.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Northrop Grumman.

???? Bullish Takeaways

Deutsche Bank turned more constructive, upgrading Northrop Grumman to Buy and lifting its price target to $700 from $575, arguing that strong free cash flow after 2028 as the B-21 bomber becomes cash profitable and Sentinel moves toward production supports a higher valuation over time.

Bernstein, with a Market Perform rating and a price target increase to $674 from $630, highlights Northrop as a key beneficiary of the 2026 budget proposal, citing significantly higher funding for Sentinel, B-21, TACAMO, E-2D, and Golden Dome programs, which underpins growth momentum and long term visibility.

Truist, which maintains a Buy rating while raising its target to $688 from $625, points to solid sector sentiment and resilient demand trends ahead of Q3, reinforcing confidence in Northrop’s execution on core programs even as broader aerospace and defense dynamics remain nuanced.

Across these firms, analysts reward Northrop’s exposure to nuclear deterrence, munitions, missiles, and space as aligned with Department of Defense strategic priorities, seeing this focus and program mix as a support for both the current multiple and future growth.

???? Bearish Takeaways

JPMorgan’s Seth Seifman keeps a Neutral rating even while raising the price target to $640 from $575, signaling that while the outlook is viewed as “stable” and fiscal 2026 guidance suggests mid single digit organic growth with potential upside, much of this may already be reflected in the share price.

Truist and JPMorgan both flag near term uncertainties, including the looming government shutdown and its impact on Q4 and FY26 outlooks, which temper enthusiasm despite higher targets and contribute to a more measured stance on how much additional upside is justified at current valuation levels.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

The Pentagon is reportedly days away from selecting the contractor for the Navy's next generation F/A XX stealth fighter, with Northrop Grumman going head to head with Boeing for a multibillion dollar program that could reshape its combat aircraft franchise.

The U.S. Defense Department is pressing missile suppliers to double or even quadruple output, a production surge that could support higher long term revenue for Northrop Grumman given its involvement in multiple high demand missile systems.

Northrop Grumman is among a group of major defense contractors under heightened scrutiny as Defense Secretary Pete Hegseth convenes top military commanders for an urgent strategy session at a Marine Corps base in Virginia, signaling potential shifts in procurement priorities.

Possible changes to U.S. arms export rules aimed at easing sales of advanced military drones could open new international markets for Northrop Grumman's unmanned systems portfolio, expanding its addressable demand beyond existing programs.

Fair value estimate is essentially unchanged at approximately $667.21 per share, indicating no material shift in the intrinsic value assessment.

The discount rate has risen slightly from about 7.93% to roughly 8.20%, implying a modestly higher required return and risk premium.

Revenue growth is effectively flat at around 5.43%, reflecting a stable outlook for top line expansion.

The net profit margin is unchanged at approximately 9.39%, signaling no revised expectations for underlying profitability.

The future P/E has risen slightly from about 25.32x to roughly 25.51x, suggesting a marginally higher valuation multiple on forward earnings.

Narratives on Simply Wall St turn raw numbers into a clear story. They connect a company’s mission, competitive position, and risks to a quantified forecast for revenue, earnings, and margins, and then to an estimated fair value. Within the Community page, millions of investors use Narratives as an easy tool to compare Fair Value with the current share price, decide when to buy or sell, and see their view automatically update as fresh news, guidance, or earnings roll in.

Head over to the Simply Wall St Community and follow the Narrative on Northrop Grumman to stay on top of:

How elevated global defense spending and next generation platforms like B 21 and Sentinel could support long term cash flows and margin strength.

Whether heavy reliance on large U.S. contracts and shifting allied priorities begin to challenge growth and international positioning.

How analysts’ assumptions for 5.5% annual revenue growth, 9.3% margins, and a 23.2x PE translate into an updated Fair Value versus today’s price.

Read the full Northrop Grumman Narrative and track every update in real time.

Curious how numbers become stories that shape markets? Explore Community Narratives

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NOC.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com